BiotechTube
Home/Junevity/Yi Jin
YJ

Yi Jin

VP of siRNA Therapeutic Development

Junevity

Therapeutic Areas

Metabolic DiseaseNeurodegeneration

Junevity Pipeline

DrugIndicationPhase
UndisclosedMetabolic DiseasePre-clinical

Leadership Team at Junevity

JH
John Hoekman
Co-founder & CEO
JS
Janine Sengstack
Co-founder & CSO
RC
Rob Cahill
Co-founder, COO & CBO
HL
Hao Li
Co-founder & UCSF Professor
View full Junevity profile